The accompanying notes are an integral part of these unaudited consolidated financial statements.
The accompanying notes are an integral part of these unaudited consolidated financial statements.
The accompanying notes are an integral part of these unaudited consolidated financial statements.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization, Nature of Business and Trade Name
Our business address is 312 S. Beverly Drive #3102, Beverly Hills, California 90212. 1PM Industries (“1PM”, “we”, “us”, “our”, the “Company” or the “Registrant”) was originally incorporated in the State of Colorado on March 26, 1990 under the name of Southshore Corporation and changed our name to Torrent Energy Corp. on July 15, 2004 and changed our name to 1PM Industries on February 19, 2015. On June 5, 2014, the Company executed a merger with Embarr Farms, Inc. On June 5, 2014, the Company entered into an Agreement whereby the Company acquired 100% of Embarr Farms, Inc. Embarr Farms was the surviving Company and became a wholly owned subsidiary of the Company and changed the name of the Company to 1PM Industries. The Company selected February 28 as its fiscal year end. On February 23, 2017, the Company acquired 100% of Novus Group LLC (dba NG Advisors), which became our wholly owned subsidiary.
Our main business is providing consulting services to a wide variety of companies in diverse industries transform from a private company to a public company. We target companies that are in the start-up phase of their operations. We intend to assist the companies by incubating them and then merging the company into a public company through a reverse merger.
Basis of Presentation of Interim Financial Statements
The accompanying unaudited consolidated financial statements of 1PM Industries, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report filed with the SEC on Form 10-K, on June 14, 2017. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the consolidated financial statements which would substantially duplicate the disclosure contained in the audited consolidated financial statements for the most recent fiscal year 2017 as reported in Form 10-K filed on June 14, 2017, have been omitted.
Principles of Consolidation
The consolidated financial statements include the accounts of 1PM Industries, Inc. and its subsidiaries. Intercompany transactions and balances have been eliminated.
Variable Interest Entities
The Company follows ASC 810-10-15 guidance with respect to accounting for variable interest entities (each, a “VIE”). These entities do not have sufficient equity at risk to finance their activities without additional subordinated financial support from other parties or whose equity investors lack any of the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions of a VIE’s expected losses or receive portions of its expected residual returns and are contractual, ownership, or pecuniary in nature and that change with changes in the fair value of the entity’s net assets. A reporting entity is the primary beneficiary of a VIE and must consolidate it when that party has a variable interest, or combination of variable interests, that provides it with a controlling financial interest. A party is deemed to have a controlling financial interest if it meets both of the power and losses/benefits criteria. The power criterion is the ability to direct the activities of the VIE that most significantly impact its economic performance. The losses/benefits criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE that could potentially be significant to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the primary beneficiary of a VIE due to changes in facts and circumstances.
The Company has entered into certain transactions with VIEs during the period; however, the Company is not considered to be the Primary beneficiary in these transactions.
Derivative financial instruments
Derivative financial instruments are initially measured at fair value on the contract date and are subsequently remeasured to fair value at each reporting date. The Company designates certain derivatives as hedges of the change of fair value of recognized assets and liabilities (“fair value hedges”). Hedge accounting is discontinued when the hedging instrument expires or is sold, terminated or exercised, no longer qualifies for hedge accounting or the Company chooses to end the hedging relationship.
Fair Value of Financial Instruments
As defined in ASC 820
”Fair Value Measurements,”
fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
The following table summarizes fair value measurements by level at November 30, 2017 and February 28, 2017, measured at fair value on a recurring basis:
November 30, 2017
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in marketable securities – available for sale
|
|
$
|
76,452
|
|
|
$
|
50,000
|
|
|
$
|
-
|
|
|
$
|
126,452
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
2,254,119
|
|
|
$
|
2,254,119
|
|
February 28, 2017
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in marketable securities – available for sale
|
|
$
|
12,206,493
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
12,206,493
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
494,785
|
|
|
$
|
494,785
|
|
Reclassification
Certain prior period amounts have been reclassified to conform to current period presentation.
Recent Accounting Pronouncements
In September 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.
NOTE 2 – GOING CONCERN
The Company’s consolidated financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has minimal revenue to cover its operating costs, and it does not have sufficient cash flow to maintain its operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company expects to develop its business and thereby increase its revenue. However, the Company would require sufficient capital to be invested into the Company to acquire the properties to begin generating sufficient revenue to cover the monthly expenses of the Company. Until the Company is able to generate revenue, the Company would be required to raise capital through the sale of its stock or through debt financing. Management may raise additional capital through future public or private offerings of the Company’s stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders. Our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
To this date the Company has relied on loans from related parties, mainly from its officers and directors, to finance its operations and growth. The Company expects to continue to fund the Company through debt and securities sales and issuances until the Company generates enough revenues through the operations. These transactions will initially be through related parties, such as the Company’s officers and directors.
NOTE 3 – NOTES RECEIVABLE
The Company has advanced funds to certain unrelated companies, over multiple periods, and issued notes receivable for these amounts. The notes receivable are unsecured, 0% interest bearing for the initial 9 months and then 5% interest bearing and payable on December 31, 2018.
During the nine months ended November 30, 2017, the Company advanced $476,125 to certain unrelated companies. As of November 30, 2017 and February 28, 2017, the Company had notes receivable of $481,125 and $5,000, respectively.
Variable Interest Entity
The Company has performed an analysis of the notes receivable balance under ASC 810-10, and has determined the notes receivable in these unrelated companies are variable interest entities (“VIE”) and depends on the Company, as well as additional parties, for continuing financial support in order to maintain operations. However, the Company cannot make key operating decisions considered to be most significant to the VIE, and is therefore not considered to be the primary beneficiary. The Company’s maximum exposure to loss approximates to the carrying value of the notes receivable balance at November 30, 2017.
NOTE 4 – MARKETABLE SECURITIES
On April 4, 2017, the Company entered into a consulting agreement and acquired non-voting convertible Series A Preferred Stock. As of November 30, 2017, the Company recorded deferred revenue of $50,000 as this consulting service was not completed. The Series A Preferred Stock is convertible into 9.9% of the common stock of a company who we identified as a VIE (Note 3).
The following table shows the Company’s available-for-sale securities as of November 30, 2017:
|
|
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
101,936 shares of common stock
|
|
$
|
10,194
|
|
|
$
|
66,258
|
|
|
$
|
-
|
|
|
$
|
76,452
|
|
Convertible Series A Preferred Stock
|
|
|
50,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
50,000
|
|
|
|
|
60,194
|
|
|
|
66,258
|
|
|
|
-
|
|
|
|
126,452
|
|
During the nine months ended November 30, 2017, the Company purchased 640,000 shares for approximately $64,000 and sold 4,045,677 shares in its common stock investment, received cash of $1,896,855 and recorded a gain on sale of marketable securities of $1,833,402.
The Company fair valued the marketable security in common stock at November 30, 2017 and recorded an unrealized loss on change in fair value of $12,130,588.
NOTE 5 – RELATED PARTY TRANSACTIONS
Related party note payable
In conjunction with the process of product development, the Company borrowed from WB Partners, LLC, which is owned by an officer of the Company. The note is a unsecured non-interest bearing promissory note that is payable on December 31, 2018. The Company used 20% to impute interest on the non-interest bearing note. The discount is being amortized over the term of the note.
During the nine months ended November 30, 2017, the Company borrowed a total amount of $305,559 from WB Partners, LLC and repaid $454,090 for the above note. Additionally, the Company recorded a discount of $12,124 for the nine months ended November 30, 2017, for the imputed interest of 20%.
As of November 30, 2017, and February 28, 2017, the Company owed a note payable – related party of $37,577 net of a $819 debt discount and $161,946 net of a $24,980 debt discount, respectively. During the nine months ended November 30, 2017 and 2016, the Company recognized amortization of debt discount of $12,037 and $9,915, respectively.
Equity
During the period ended November 30, 2017 and 2016, there were distributions to preferred stock holders of $701,089 and $0, respectively.
NOTE 6 – CONVERTIBLE NOTES PAYABLE
The Company had the following convertible notes payable outstanding as of November 30, 2017 and February 28, 2017:
|
|
November 30,
|
|
|
February 28,
|
|
|
|
2017
|
|
|
2017
|
|
Unsecured Promissory Note - Issued December 10, 2015
|
|
$
|
8,700
|
|
|
$
|
66,461
|
|
Unsecured Promissory Note - Issued in fiscal year 2017
|
|
|
48,676
|
|
|
|
128,820
|
|
Unsecured Promissory Note - Issued in fiscal year 2018
|
|
|
342,100
|
|
|
|
-
|
|
Total convertible notes payable
|
|
|
399,476
|
|
|
|
195,281
|
|
Less: debt discount and deferred financing fees
|
|
|
(108,384
|
)
|
|
|
(74,905
|
)
|
|
|
|
291,092
|
|
|
|
120,376
|
|
Less: current portion of convertible notes payable
|
|
|
265,218
|
|
|
|
115,107
|
|
Long-term convertible notes payable
|
|
$
|
25,874
|
|
|
$
|
5,269
|
|
During the nine months ended November 30, 2017 and 2016, the Company recognized amortization of discount of $413,521 and $187,844, respectively.
Promissory Note – December 10, 2015
On December 10, 2015, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued a convertible note in the amount of $170,000, which included an original issue discount (“OID”) of $20,000, for net proceeds to be provided of $150,000. Pursuant to the terms of the note, net proceeds of $45,000 were received upon closure of the agreement, on which the Company recognized a pro-rated OID of $15,000 in addition to the cash proceeds and two investor notes for $50,000 each. The debt is convertible upon effective date of the note, debt holder can convert into common stock at $0.30 per share unless market capitalization falls below $10M at any time in which the conversion rate is reset to lower of conversion price and market price with a true-up provision. In addition to the convertible note, the Company granted to the same investor the right to purchase, at any time, three five−year 100,000 fully paid and non-assessable cashless warrants of Company’s common stock. The exercise price of the cashless warrants are $0.30 unless, while warrant is outstanding, the Company sells any common stock, debt, warrants, options, preferred shares or other instruments or securities which are convertible into or exercisable for shares of common stock, at an effective price per share less than the exercise price then such price shall become the exercise price.
The Company identified conversion features embedded within convertible debt and warrants issued during 2016 and 2015. The Company has determined that the conversion feature of the Notes represents an embedded derivative since the Notes include a reset provision which could cause adjustments upon conversion. Accordingly, the Notes are not considered to be conventional debt and the embedded conversion feature must be bifurcated from the debt host and accounted for as a derivative liability. The warrants are exercisable into 283,334 shares of common stock, for a period of five years from issuance, at a price of $0.30 per share. As a result of the reset features the warrants became exercisable into 850,002 shares of common stock at $0.00085 per share. The reset feature of warrants associated with this convertible note was effective at the time that a separate convertible note with lower exercise price was issued. Per the terms of the warrants, once this separate convertible note was issued the reset feature was effective. The reset provision calls for the increase in warrants not to exceed a number equal to 3 times the number of warrant shares issuance under this warrant as of the issue date
Promissory Notes - Issued in fiscal year 2017
During the year ended February 28, 2017, the Company issued a total of $227,500 notes with the following terms:
|
·
|
Terms ranging from 9 months to 2 years.
|
|
|
|
|
·
|
Annual interest rates of 10% - 12%.
|
|
|
|
|
·
|
Convertible at the option of the holders either at issuance or 180 days from issuance. The note dated June 6, 2016 is convertible at September 6, 2016.
|
|
|
|
|
·
|
Conversion prices are typically based on the discounted (35% to 60% discount) lowest trading prices of the Company’s shares during various periods prior to conversion. Certain notes allow for the conversion price to be the lower of the closing sale price or the discounted trading price.
|
Certain notes allow the Company to redeem the notes at rates ranging from 125% to 145% depending on the redemption date provided that no redemption is allowed after the 180th day. Likewise, certain notes include original issue discounts totaling to $34,600 and the Company received cash of $192,900.
During the nine months ended November 30, 2017, the Company amended the term of one convertible note issued in fiscal year 2017 and recorded loss on debt extinguishment of $164,277.
The Company identified conversion features embedded within certain notes and warrants issued during 2016. The Company has determined that the conversion feature of the Notes represents an embedded derivative since the conversion price is variable and the Notes include a reset provision which could cause adjustments upon conversion. Accordingly, the Notes are not considered to be conventional debt and the embedded conversion feature must be bifurcated from the debt host and accounted for as a derivative liability. On issuance, the warrants were exercisable into 1,875,000 and 10,181,704 shares of common stock, for a period of five years from issuance, at a price of $0.10 and $0.0059 per share, respectively. We accounted for the issuance of the Warrants as a derivative. As a result of the reset features, the warrants increased by 2,707,906,392 and 20,363,408 during the nine months November 30, 2017, respectively, the total warrants are exercisable into 2,562,499,994 and 30,545,112 shares of common stock at $0.00004 and $0.00085 per share, respectively. We accounted for the issuance of the Warrants as a derivative.
The Company determined that the conversion feature met the definition of a liability in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and therefore bifurcated the embedded conversion option once the note becomes convertible and accounted for it as a derivative liability. The fair value of the conversion feature was recorded as a debt discount and amortized to interest expense over the term of the note.
Promissory Notes - Issued in fiscal year 2018
During the nine months ended November 30, 2017, the Company issued a total of $390,000 note with the following terms:
|
·
|
Terms ranging from 9 months to 2 years.
|
|
|
|
|
·
|
Annual interest rates of 10 - 12%.
|
|
|
|
|
·
|
Convertible at the option of the holders at issuance.
|
|
|
|
|
·
|
Conversion prices are typically based on the discounted (40% to 60% discount) lowest trading prices of the Company’s shares during various periods prior to conversion.
|
The notes allow the Company to redeem the note at rates of 125%. Likewise, the note includes original issue discounts totaling to $65,000 and the Company received cash of $325,000.
The Company identified conversion features embedded within certain notes and warrants issued during the period ended November 30, 2017. The Company has determined that the conversion feature of the Notes represents an embedded derivative since the conversion price is variable and the Notes include a reset provision which could cause adjustments upon conversion. Accordingly, the Notes are not considered to be conventional debt and the embedded conversion feature must be bifurcated from the debt host and accounted for as a derivative liability. The warrants are exercisable into 129,629,630 shares of common stock, for a period of five years from issuance, at a price of $0.0059 per share. As a result of the reset features, the warrants increased by 259,259,260 and the total warrants exercisable into 388,888,890 shares of common stock at $0.00004 per share. We accounted for the issuance of the Warrants as a derivative.
The Company determined that the conversion feature met the definition of a liability in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and therefore bifurcated the embedded conversion option once the note becomes convertible and accounted for it as a derivative liability. The fair value of the conversion feature was recorded as a debt discount and amortized to interest expense over the term of the note.
The Company valued the conversion feature using the Black Scholes valuation model. The fair value of the derivative liability for all the note and warrants that became convertible for nine months ended November 30, 2017 amounted to $1,440,974. $382,500 of the value assigned to the derivative liability was recognized as a debt discount to the notes while the balance of $1,115,974 was recognized as a “day 1” derivative loss.
Conversion
During the nine months ended November 30, 2017, the Company converted notes with principal amounts and accrued interest of $315,307 into 1,804,666,649 shares of common stock. The corresponding derivative liability at the date of conversion of $2,158,959 was credited to additional paid in capital.
Warrants
A summary of activity during the period ended November 30, 2017 follows:
|
|
Warrants Outstanding
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
Shares
|
|
|
Exercise Price
|
|
|
|
|
|
|
|
|
Outstanding, February 28, 2017
|
|
|
42,811,367
|
|
|
$
|
0.0059
|
|
Granted
|
|
|
129,629,630
|
|
|
|
0.0059
|
|
Reset features
|
|
|
2,987,529,060
|
|
|
|
0.00010
|
|
Exercised
|
|
|
(177,186,059
|
)
|
|
|
0.00085
|
|
Forfeited/canceled
|
|
|
-
|
|
|
|
-
|
|
Outstanding, November 30, 2017
|
|
|
2,982,783,998
|
|
|
$
|
0.00005
|
|
The following table summarizes information relating to outstanding and exercisable warrants as of November 30, 2017:
Warrants Outstanding
|
|
|
Warrants Exercisable
|
|
Number of Shares
|
|
|
Weighted Average Remaining
|
|
|
Weighted Average
|
|
|
Number of
|
|
|
Weighted
|
|
Contractual life (in years)
|
|
|
Exercise Price
|
|
|
Exercise Price
|
|
|
Shares
|
|
|
Average
|
|
|
850,002
|
|
|
|
3.03
|
|
|
$
|
0.00085
|
|
|
|
850,002
|
|
|
$
|
0.00085
|
|
|
2,562,499,994
|
|
|
|
3.70
|
|
|
|
0.00004
|
|
|
|
2,562,499,994
|
|
|
|
0.00004
|
|
|
30,545,112
|
|
|
|
4.09
|
|
|
|
0.00085
|
|
|
|
30,545,112
|
|
|
|
0.00085
|
|
|
388,888,890
|
|
|
|
4.42
|
|
|
|
0.00004
|
|
|
|
388,888,890
|
|
|
|
0.00004
|
|
|
2,982,783,998
|
|
|
|
3.80
|
|
|
$
|
0.00005
|
|
|
|
2,982,783,998
|
|
|
$
|
0.00005
|
|
Aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company’s stock exceeded the exercise price of the warrants at November 30, 2017 and February 28, 2017 for those warrants for which the quoted market price was in excess of the exercise price. The warrants have intrinsic value of $472,222 and $0 at November 30, 2017 and February 28, 2017.
NOTE 7 –
DERIVATIVE LIABILITIES
The Company analyzed the conversion option for derivative accounting consideration under ASC 815, Derivatives and Hedging, and determined that the instrument should be classified as a liability since the conversion option becomes effective at issuance resulting in there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options.
ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item.
The Company determined our derivative liabilities to be a Level 3 fair value measurement and used the Black-Scholes pricing model to calculate the fair value as of November 30, 2017. The Black-Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each convertible note is estimated using the Black-Scholes valuation model. The following weighted-average assumptions were used in the November 30, 2017 and February 28, 2017 valuations:
|
|
Nine Months
Ended
|
|
|
Year Ended
|
|
|
|
November 30,
2017
|
|
|
February 28,
2017
|
|
Expected life in years
|
|
0.02 - 5.00
|
|
|
0 - 5.00
|
|
Stock price volatility
|
|
245 - 567
|
%
|
|
187 - 490
|
%
|
Risk free interest rate
|
|
0.56 - 2.14
|
%
|
|
0.3 - 2.07
|
%
|
Expected dividends
|
|
|
None
|
|
|
|
None
|
|
The following table summarizes the changes in the derivative liabilities during the nine months ended November 30, 2017:
Balance - February 28, 2017
|
|
$
|
494,785
|
|
Addition of new derivative recognized as debt discounts
|
|
|
382,500
|
|
Addition of new derivatives recognized as loss on derivatives
|
|
|
1,115,974
|
|
Derivatives settled upon conversion of debt
|
|
|
(2,158,958
|
)
|
Loss on debt extinguishment
|
|
|
164,277
|
|
Re-measurement – November 30, 2017
|
|
|
|
|
Loss on change in fair value of the derivative
|
|
|
2,255,541
|
|
Balance - November 30, 2017
|
|
$
|
2,254,119
|
|
The net loss on derivatives during the nine months ended November 30, 2017 and 2016 was $3,371,515 and $413,265, respectively.
NOTE 8 – EQUITY
Series F Preferred Stock
There were no issuances of the Series F Preferred Stock during the nine months ended November 30, 2017.
Common Stock
During the nine months ended November 30, 2017, the Company issued and cancelled common stock, as follows;
|
·
|
19,736,842 shares of common stock for services with a fair value of $110,526
|
|
|
|
|
·
|
1,804,666,649 shares of common stock were issued for the conversion of debt and accrued interest of $315,307.
|
|
|
|
|
·
|
241,500,000 shares of common stock were issued in exchange for 285,881,711 cashless warrants. Of these issuances, 100,000,000 shares of common stock were cancelled by the holder and 108,695,652 warrants returned back to the holder, by the Company.
|
Distribution
During the period ended November 30, 2017 and 2016, there were distributions to preferred stock holders of $701,089 and $0, respectively.
NOTE 9 – DISCONTINUED OPERATIONS
On October 14, 2016, the Company decided to exit the field of medical marijuana edibles marketed under the Von Baron Farms brand.
The change of the business qualified as a discontinued operation of the Company and accordingly, the Company has excluded results of the operations from its Consolidated Statements of Operations to present this business in discontinued operations.
The following table shows the results of operations of 1PM for the period ended November 30, 2016 which are included in the loss from discontinued operations:
|
|
Three Months
Ended
|
|
|
Nine Months
Ended
|
|
|
|
November 30,
|
|
|
November 30,
|
|
|
|
2016
|
|
|
2016
|
|
Revenue
|
|
$
|
6,845
|
|
|
$
|
49,358
|
|
Cost of goods
|
|
|
4,790
|
|
|
|
28,013
|
|
Gross profit
|
|
|
2,055
|
|
|
|
21,345
|
|
Selling and administrative expenses
|
|
|
33,922
|
|
|
|
1,039,024
|
|
Operating loss
|
|
|
(31,867
|
)
|
|
|
(1,017,679
|
)
|
Earnings from discontinued operations before income taxes
|
|
|
(31,867
|
)
|
|
|
(1,017,679
|
)
|
Income tax provision
|
|
|
-
|
|
|
|
-
|
|
Loss from discontinued operations, net of tax
|
|
$
|
(31,867
|
)
|
|
$
|
(1,017,679
|
)
|
NOTE 10 – SUBSEQUENT EVENT
Subsequent to November 30, 2017, the Company issued 418,400,000 shares of common stock for conversion of debt and accrued interest of $17,653.